Key statistics
On Thursday, Legend Biotech Corp (LEGN:NSQ) closed at 39.75, 7.67% above its 52-week low of 36.92, set on Nov 19, 2024.
52-week range
Open | 40.18 |
---|---|
High | 40.73 |
Low | 39.09 |
Bid | 39.19 |
Offer | 40.75 |
Previous close | 40.14 |
Average volume | 1.80m |
---|---|
Shares outstanding | 184.29m |
Free float | 181.21m |
P/E (TTM) | -- |
Market cap | 7.40bn USD |
EPS (TTM) | -1.91 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights
- Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition
- Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma
- Legend Biotech Appoints Alan Bash as President of CARVYKTI®
- Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results
- Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
- CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line
- Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights
- Legend Biotech Appoints Peter Salovey, Ph.D., to its Board of Directors
More ▼